Carolyn Johnston

University of Tasmania — Australia

Health Professions · Health Sciences

21h-index2.4kcitations134works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Ethics in medical practice(24), Ethics and Legal Issues in Pediatric Healthcare(23), Endometrial and Cervical Cancer Treatments(21), Ovarian cancer diagnosis and treatment(16), Palliative Care and End-of-Life Issues(10)

Publications133 total

Including Parents in Clinical Ethics Case Consultation
Journal of Paediatrics and Child Health·2025
Author Correction: Returning raw genomic data to research participants in a pediatric cancer precision medicine trial
npj Genomic Medicine·2025Open Access
Returning raw genomic data to research participants in a pediatric cancer precision medicine trial
npj Genomic Medicine·2025Open Access
Ownership of genomic data
Internal Medicine Journal·2024Open Access
Policy and process for returning raw genomic data to parents and young adult participants in a pediatric cancer precision medicine trial.
2024Open Access
They Can Have Our Cake - But Can We Eat It? Access to Raw Genomic Data under Australian Privacy Law.
PubMed·2023· 3 cited
Supplementary Table 1 from Phase II Trial of Cabozantinib in Recurrent/Metastatic Endometrial Cancer: A Study of the Princess Margaret, Chicago, and California Consortia (NCI9322/PHL86)
2023Open Access
Data from Phase II Trial of Cabozantinib in Recurrent/Metastatic Endometrial Cancer: A Study of the Princess Margaret, Chicago, and California Consortia (NCI9322/PHL86)
2023Open Access
Supplementary Table 1 from Phase II Trial of Cabozantinib in Recurrent/Metastatic Endometrial Cancer: A Study of the Princess Margaret, Chicago, and California Consortia (NCI9322/PHL86)
2023Open Access
Data from Phase II Trial of Cabozantinib in Recurrent/Metastatic Endometrial Cancer: A Study of the Princess Margaret, Chicago, and California Consortia (NCI9322/PHL86)
2023Open Access
Data from Aldehyde Dehydrogenase in Combination with CD133 Defines Angiogenic Ovarian Cancer Stem Cells That Portend Poor Patient Survival
2023Open Access
Supplementary Tables 1-3, Figures 1-3 from Aldehyde Dehydrogenase in Combination with CD133 Defines Angiogenic Ovarian Cancer Stem Cells That Portend Poor Patient Survival
2023Open Access
Data from Aldehyde Dehydrogenase in Combination with CD133 Defines Angiogenic Ovarian Cancer Stem Cells That Portend Poor Patient Survival
2023Open Access
Supplementary Tables 1-3, Figures 1-3 from Aldehyde Dehydrogenase in Combination with CD133 Defines Angiogenic Ovarian Cancer Stem Cells That Portend Poor Patient Survival
2023Open Access
Contributors
Elsevier eBooks·2023
Process Mapping
Elsevier eBooks·2023· 1 cited
AI in the diagnosis of health conditions
2022· 1 cited
Internet of Things and personalised medicine
2022
Smartphone apps for mental health
2022
Digital Health Technologies
2022· 2 cited
page 1 of 7Next →

Frequent Co-authors

Deborah K. Armstrong(6), Ronald D. Alvarez(6), David M. Gershenson(6), Paul Sabbatini(6), Heidi J. Gray(5), David M. O’Malley(5), Richard T. Penson(5), Steven W. Remmenga(5), Theresa L. Werner(5), Robert J. Morgan(5), Larry J. Copeland(5), Ursula A. Matulonis(5), Ardeshir Hakam(4), Lee-may Chen(4), Marta A. Crispens(4), Laura J. Havrilesky(4), Shashikant Lele(4), Joseph T. Santoso(4), Shitanshu Uppal(4), Karen McLean(3)